Purpose: to compare outcomes for uncomplicated versus complex eyes after implantation of AcrySof toric intraocular lenses (IOLs) (Alcon Laboratories Inc) in a retrospective series of cataractous astigmatic eyes.
Methods: toric IOLs were implanted in 230 eyes of 162 adult patients. Approximately half (52%, n=120) the eyes had no complications (uncomplicated group). The other 110 (48%) eyes (complex group) had a variety of complexities, including retinal or macular problems (eg, age-related macular degeneration), angle or pressure problems (eg, glaucoma), or high astigmatism that required adjunctive limbal relaxing incisions (LRIs). Outcomes were retrospectively assessed approximately 6 weeks after surgery.
Results: preoperative corneal astigmatism was 1.60 ± 1.20 diopters (D) overall (1.40 ± 0.70 D in the uncomplicated group and 1.90 ± 1.60 D in the complex group). Residual cylinder was 0.40 ± 0.60 D overall (P<.01 compared to baseline) and was significantly lower (P<.01) for the uncomplicated group (0.30 ± 0.40 D) than for the complex group (0.50 ± 0.80 D), which contained the adjunctive LRI subgroup (residual cylinder 0.80 ± 0.70 D). A larger percentage of uncomplicated eyes (26%) than complex eyes (16%) had at least 20/20 uncorrected distance visual acuity (UDVA) (P=.05). Excluding eyes with intentionally targeted myopic postoperative spherical equivalent, no eyes lost Snellen lines of UDVA, and the average improvement in UDVA was 0.8 ± 0.6 logMAR. Corrected distance visual acuity of the retinal/macular subgroup was poorer than the uncomplicated group pre- and postoperatively but was significantly improved by the surgery (P<.001; average improvement approximately 3 Snellen lines).
Conclusions: AcrySof toric IOLs reduced cylinder and improved UDVA in both complex and uncomplicated eyes with cataractous astigmatism.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.3928/1081597X-20100325-01 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Refractive Outcomes After Cataract Surgery-The Impact of Preoperative Visual Acuity, the Intraocular Lens Model, and the Surgeon's Experience: An Empirical Analysis of Hungarian and Kosovan Patients.
J Clin Med
November 2024
Department of Ophthalmology, Semmelweis University, 1085 Budapest, Hungary.
Phacoemulsification and intraocular lens (IOL) implantation comprise a standard procedure for cataract treatment. However, minimal refractive error remains a determinant of postoperative results. Our study aimed to evaluate the refractive outcomes and the impact of the surgeon's experience and the IOL model on Kosovan and Hungarian patients after cataract surgery.
View Article and Find Full Text PDFPurpose: To assess visual outcomes and stability of lens alignment more than 3 years after implanting either the AT Lisa Tri Toric (Carl Zeiss Meditec) or the Acrysof IQ Restor Toric (Alcon Laboratories, Inc) intraocular lens (IOL).
Methods: Patients who had received either the AT Lisa Tri Toric or the Acrysof IQ Restor Toric IOL were included in the study. The average follow-up period was 5.
The Clareon Vs AcrySof PanOptix Trifocal IOL: A Comparative Study of Patient Satisfaction and Visual Performance.
Clin Ophthalmol
October 2024
Florida Vision Institute, Stuart, FL, USA.
Purpose: To evaluate patient-reported outcomes of cataract surgery using the Clareon Panoptix and Panoptix Toric trifocal lenses and to compare these to the data collected previously for the AcrySof Panoptix and Panoptix Toric.
Patients And Methods: Prospective, open-label, multicenter analysis of satisfaction, spectacle independence, presence of unwanted side effects, and best-corrected visual acuity among patients undergoing cataract surgery who had been implanted at least 1 month previously with the Clareon PanOptix or PanOptix Toric trifocal IOL bilaterally. Results were compared to outcomes measured two years ago from a similar study with the AcrySof version of the same lens.
Functional outcomes and quality of life after AcrySof IQ Vivity intraocular lens implantation in a real-world study.
Sci Rep
September 2024
Ophthalmology Unit, Agostino Gemelli University Polyclinic, Rome, Italy.
The extended depth-of-focus AcrySof IQ Vivity intraocular lens technology offers promising features for presbyopia management, evaluated in this research in a 6 months real-world setting. Prospective interventional mono-centric study including 40 patients who underwent elective bilateral phacoemulsification. We performed one pre-operative visit (V0) and one evaluation six months post-operatively (V1), evaluating uncorrected and corrected visual acuity for near (UNVA/CNVA), intermediate (UIVA/CIVA) and far (UDVA/UCVA), slit-lamp evaluation, tomography with static pupillometry, endothelial cell count and contrast sensitivity chart.
View Article and Find Full Text PDFVisual outcomes following bilateral implantation of a non-diffractive extended depth of focus toric intraocular lens using a mini-monovision approach.
Int Ophthalmol
July 2024
LEC Eye Centre, 44-46, Persiaran Greenhill, 30450, Ipoh, Perak, Malaysia.
Purpose: To evaluate the clinical outcomes following bilateral implantation of the AcrySof™ IQ Vivity™ toric extended depth of focus (EDOF) intraocular lens (IOL).
Design: Prospective interventional case series.
Methods: Patients with bilateral significant cataracts and pre-existing corneal astigmatism underwent cataract surgery and implantation with the AcrySof™ IQ Vivity™ toric IOL.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!